Virtual for Care Atrial Fibrillation Patients Using VIRTUES

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04599114
Collaborator
Cardiac Arrhythmia Network of Canada (Other)
300
3
1
48
100
2.1

Study Details

Study Description

Brief Summary

Patients will atrial fibrillation, a type of irregular heart rhythm, frequently go to the emergency room in order to manage their condition. This study will use a chart review to look at the characteristics and frequency of atrial fibrillation patients who go to the emergency room. In addition to the chart review, patients with atrial fibrillation who have recently gone to the emergency room or have been hospitalized will be approached and asked if they want to use an electronic health care system that can be accessed by both themselves and their health care providers. Along with the system, patients will be given a Health Canada approved heart rhythm sensor, so patients will be able to record their heart rhythm when they feel symptoms and send the information to the heart rhythm team. The heart rhythm team will then make real-time recommendations to the patient about how they can manage their rhythm and symptoms. Patients will be asked to complete satisfaction and quality of life surveys. Our goal is to provide efficient and effective care for patients with AF, resulting in decreased repeat ED visits.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: VIRTUES
N/A

Detailed Description

See brief summary.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This study will use a retrospective chart review to examine characteristics of patients who present to the emergency room with atrial fibrillation as well as a non-randomized prospective cohort who will be offered enrollment into the virtual platform.This study will use a retrospective chart review to examine characteristics of patients who present to the emergency room with atrial fibrillation as well as a non-randomized prospective cohort who will be offered enrollment into the virtual platform.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Virtual for Care Atrial Fibrillation Patients Using VIRTUES (Virtual Integrated Reliable Transformative User-Driven E-Health System)
Anticipated Study Start Date :
Nov 1, 2020
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: VIRTUES Arm

Patients in the VIRTUES arm will be offered enrollment into the virtual atrial fibrillation care platform.

Behavioral: VIRTUES
VIRTUES is a digital health platform that offers 2 way communication between clinicians and patients to address symptoms stemming from atrial fibrillation.

Outcome Measures

Primary Outcome Measures

  1. Number of patients who present to the emergency department due to atrial fibrillation, after their index visit [12 months]

    See title

Secondary Outcome Measures

  1. Number of AF-related ER visit per patient, post index visit [12 months]

    See title

  2. Utility of the system [12 months]

    Number of uses of the system/patient, number of accesses to the health record, number of heart rhythm VIRTUES team - patient feedbacks on the VIRTUES app, percentage of care plans followed by the patient

  3. Survey-based experience with the VIRTUES application [Baseline, 3 months, 12 months]

    Survey-based experience will be determined by the "Virtual AF Care Patient Satisfaction Questionnaire". The questionnaire consists of 5 questions regarding the VIRTUES platform using a 5 point likert scale (strongly agree to strongly disagree) in addition to a final open ended question asking for feedback regarding the application.

  4. Pre and post patient reported outcomes using the Atrial Fibrillation Effect on Quality of Life (AFEQT) Questionnaire and the EQ-5D-5L [Baseline, 3 months, 12 months]

    The Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire is a well-validated questionnaire with 2 sections. The first section asked about a patient's incidence of atrial fibrillation, the second section inquires as to the presence of atrial fibrillation symptomsand how limiting they were. In general, higher scores mean more frequent atrial fibrillation symptoms that are very/extremely limiting and bothersome.

  5. Time to stroke/TIA, systematic embolism, cardiovascular (CV) hospitalization, death [12 months]

    The length of time between index presentation for atrial fibrillation and the onset of any of the above conditions will be calculated for both the retrospective and prospective cohorts.

  6. Frequency of stroke/TIA, systematic embolism, cardiovascular (CV) hospitalization, death [12 months]

    The number of any of the above conditions occurring in both the retrospective and prospective cohorts will be counted and analyzed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • able to provide informed consent

  • documented symptomatic new-onset or pre-existing, non-valvular AF

  • ER visit or hospitalization for primary AF in the last 6 months

  • proficient in the English language

Exclusion Criteria:
  • unable to provide informed consent

  • planning to move/relocate during the period of study

  • current pregnancy

  • patient is a prisoner/incarcerated

  • no access to a smart device with Bluetooth capabilities

  • planned percutaneous coronary intervention, coronary artery bypass graphing or heart valve surgery within the next year

  • any medical condition making 1 year survival unlikely

Contacts and Locations

Locations

Site City State Country Postal Code
1 Queen Elizabeth II Health Sciences Centre Halifax Nova Scotia Canada B3H 2Y9
2 Rachel Caris London Ontario Canada N6A 5A5
3 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N 3M5

Sponsors and Collaborators

  • Lawson Health Research Institute
  • Cardiac Arrhythmia Network of Canada

Investigators

  • Principal Investigator: Allan C Skanes, Md, Lawson Health Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Allan Skanes, Director, Electrophysiology Laboratory, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT04599114
Other Study ID Numbers:
  • 4411
First Posted:
Oct 22, 2020
Last Update Posted:
Oct 22, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Allan Skanes, Director, Electrophysiology Laboratory, Lawson Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2020